ASTRO 2018: High-Dose Radiotherapy Improves Survival Substantially in Patients With Oligometastatic Cancer
Stereotactic ablative radiation therapy doubles PFS in patients with oligometastatic cancer.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.